Aziz Sawaf

Insider Reports History

Entity
Individual
Location
901 Gateway Blvd, South San Francisco, CA
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aziz Sawaf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP & CHIEF FINANCIAL OFFICER Ordinary Shares 313K $3.12M $9.97 Nov 20, 2024 Direct

Insider Reports Filed by Aziz Sawaf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TBPH Theravance Biopharma, Inc. Nov 20, 2024 1 -$84.5K 4 Nov 22, 2024 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Aug 20, 2024 1 -$71K 4 Aug 22, 2024 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. May 20, 2024 1 -$78.6K 4 May 22, 2024 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Apr 2, 2024 1 $0 4 Apr 4, 2024 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Feb 20, 2024 1 -$152K 4 Feb 22, 2024 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Nov 20, 2023 1 -$64.2K 4 Nov 22, 2023 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Aug 20, 2023 1 -$69K 4 Aug 22, 2023 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. May 20, 2023 1 -$98K 4 May 23, 2023 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Feb 20, 2023 1 -$70.8K 4 Feb 22, 2023 SVP & CHIEF FINANCIAL OFFICER
TBPH Theravance Biopharma, Inc. Jan 1, 2023 0 $0 3 Jan 10, 2023 SVP & Chief Financial Officer